PARIS – Better patient safety has been the single greatest benefit of Europe’s system of pharmaceuticals regulation and legislation over the past 50 years, according to an audience vote at a Regulatory Town Hall meeting, which kicked off proceedings at the Drug Information Association’s (DIA) 27th annual European meeting at Le Palais des Congrès in Paris, Monday.